Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ABT518

Known as: ABT-518 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
1. The potential of the matrix metalloproteinase (MMP) inhibitor ABT‐518 to affect pre‐adipocyte differentiation in vitro and… Expand
Highly Cited
2005
Highly Cited
2005
Tetracyclines exhibit significant anti-inflammatory properties, inhibit matrix metalloproteinases (MMPs), and are protective in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2004
Review
2004
  • C. K. Wada
  • Current topics in medicinal chemistry
  • 2004
  • Corpus ID: 10871690
Matrix metalloproteinases (MMPs) have been implicated in several pathologies. At Abbott Laboratories, the matrix… Expand
2004
2004
A liquid chromatographic/tandem mass spectrometric (LC/MS/MS) assay for the quantitative analysis of the novel anticancer drug… Expand
Highly Cited
2002
Highly Cited
2002
A novel series of sulfone N-formylhydroxylamines (retrohydroxamates) have been investigated as matrix metalloproteinases (MMP… Expand
2002
2002
Abstract Purpose. To investigate the pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase (MMP… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2001
Highly Cited
2001
ABT-770 [(S)-N-[1-[[4'-trifluoromethoxy-[1,1'-biphenyl]-4-yl]oxy]methyl-2-(4,4-dimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]-N… Expand